A study has revealed how remotely supervised transcranial direct current stimulation (RS-tDCS) can help with the treatment of fatigue in multiple sclerosis (MS) patients.
Fatigue is a common and debilitating symptom of MS and there is currently no reliable effective treatment. Transcranial direct current stimulation (tDCS) was used in a randomised, sham-controlled trial to test if it could be a treatment option for fatigue reduction.
The study, “Remotely supervised transcranial direct current stimulation for the treatment of fatigue in multiple sclerosis: Results from a randomized, sham-controlled trial”, was published online in the Multiple Sclerosis Journal.
The scientists developed a tele rehabilitation protocol that delivers tDCS to participants at home using specially designed equipment and real-time supervision.
The treatment was administered using a RS-tDCS protocol and was paired with 20 minutes of cognitive training.
There were two studies conducted. The first delivered tDCS to 10 patients, who were aware of the treatment they were receiving and compared to those who received cognitive training only. The results showed modest fatigue reduction.
The second was a randomised trial of active or sham tDCS delivered for 20 sessions. This study showed significant reduction for the active group.
From these findings the researchers concluded that tDCS is a potential treatment for MS-related fatigue.